Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-03-07 Sale |
2024-03-11 6:24 pm |
Blueprint Medicines Corp | BPMC | Murray Christopher K. CHIEF TECHNICAL OPERATIONS |
2,521 | $90.69 | $228,629 | 33,853 (Direct) |
View |
| 2024-03-04 Sale |
2024-03-06 10:41 am |
Blueprint Medicines Corp | BPMC | Murray Christopher K. CHIEF TECHNICAL OPERATIONS |
621 | $93.65 | $58,157 | 61,374 (Direct) |
View |
| 2024-02-28 Sale |
2024-03-01 3:06 pm |
Blueprint Medicines Corp | BPMC | Murray Christopher K. CHIEF TECHNICAL OPERATIONS |
5,000 | $100 | $500,000 | 32,495 (Direct) |
View |
| 2023-12-07 Sale |
2023-12-11 5:11 pm |
Blueprint Medicines Corp | BPMC | Murray Christopher K. CHIEF TECHNICAL OPERATIONS |
5,000 | $75 | $375,000 | 37,495 (Direct) |
View |
| 2023-12-04 Sale |
2023-12-06 8:45 pm |
Blueprint Medicines Corp | BPMC | Murray Christopher K. CHIEF TECHNICAL OPERATIONS |
600 | $71.43 | $42,858 | 24,495 (Direct) |
View |
| 2023-10-26 Sale |
2023-10-30 2:01 pm |
Blueprint Medicines Corp | BPMC | Murray Christopher K. CHIEF TECHNICAL OPERATIONS |
600 | $56.4 | $33,840 | 25,095 (Direct) |
View |
| 2023-03-06 Sale |
2023-03-08 9:38 pm |
Blueprint Medicines Corp | BPMC | Murray Christopher K. CHIEF TECHNICAL OPERATIONS |
1,875 | $45.68 | $85,641 | 25,695 (Direct) |
View |
| 2022-08-04 Sale |
2022-08-08 6:48 pm |
Blueprint Medicines Corp | BPMC | Murray Christopher K. SVP, TECHNICAL OPERATIONS |
5,000 | $62.72 | $313,600 | 18,820 (Direct) |
View |
| 2022-03-03 Sale |
2022-03-08 4:05 pm |
Blueprint Medicines Corp | BPMC | Murray Christopher K. SVP, TECHNICAL OPERATIONS |
1,568 | $58.96 | $92,455 | 23,820 (Direct) |
View |
| 2021-03-04 Sale |
2021-03-05 5:49 pm |
Blueprint Medicines Corp | BPMC | Murray Christopher K. SVP, Technical Operations |
1,210 | $86.76 | $104,984 | 18,888 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-03-01 Option Award |
2024-03-06 10:41 am |
N/A 2034-03-01 |
Blueprint Medicines Corp | BPMC | Murray Christopher K. CHIEF TECHNICAL OPERATIONS |
37,500 | $0 | 61,374 (Direct) |
View |
| 2024-02-28 Exercise |
2024-03-01 3:06 pm |
N/A 2030-03-01 |
Blueprint Medicines Corp | BPMC | Murray Christopher K. CHIEF TECHNICAL OPERATIONS |
5,000 | $0 | 32,495 (Direct) |
View |
| 2024-02-28 Exercise |
2024-03-01 3:06 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Murray Christopher K. CHIEF TECHNICAL OPERATIONS |
5,000 | $54.13 | 32,495 (Direct) |
View |
| 2023-12-07 Exercise |
2023-12-11 5:11 pm |
N/A 2030-03-01 |
Blueprint Medicines Corp | BPMC | Murray Christopher K. CHIEF TECHNICAL OPERATIONS |
5,000 | $0 | 37,495 (Direct) |
View |
| 2023-12-07 Exercise |
2023-12-11 5:11 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Murray Christopher K. CHIEF TECHNICAL OPERATIONS |
5,000 | $54.13 | 37,495 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 8:00 pm |
N/A 2033-03-01 |
Blueprint Medicines Corp | BPMC | Murray Christopher K. CHIEF TECHNICAL OPERATIONS |
26,250 | $0 | 45,070 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 8:00 pm |
N/A 2032-03-01 |
Blueprint Medicines Corp | BPMC | Murray Christopher K. SVP, TECHNICAL OPERATIONS |
19,500 | $0 | 38,388 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 4:19 pm |
N/A 2031-03-01 |
Blueprint Medicines Corp | BPMC | Murray Christopher K. SVP, Technical Operations |
18,750 | $0 | 32,598 (Direct) |
View |